Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)

CAS: 27833-64-3

Ref. AN-AG002UW4

Información del producto

• Nombre: Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
• Sinónimos: [u'2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine', u'CL 71,563', u'CL-71,563', u'CL71,563', u'Cloxazepine', u'Hydrochloride, Loxapine', u'Loxapine', u'Loxapine Hydrochloride', u'Loxapine Monohydrochloride', u'Loxapine Succinate', u'Loxapinsuccinate', u'Loxipine Maleate', u'Loxipine Succinate', u'Loxitane', u'Maleate, Loxipine', u'Oxilapine', u'Succinate, Loxapine', u'Loxapine succinate', u'27833-64-3', u'Loxapine succinate salt', u'Cloxazepin', u'Daxolin', u'Loxapac', u'Lederle', u'Loxapine (succinate)', u'UNII-X59SG0MRYU', u'Loxapine,succinate', u'Loxapine, Succinate', u'CCRIS 1917', u'EINECS 248-682-0', u'X59SG0MRYU', u'CL 71563', u'CPD000058470', u'MLS000069383', u'MFCD00069298', u'NCGC00016160-02', u'SMR000058470', u'CAS-27833-64-3', u'2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine succinate', u'2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1)', u'DSSTox_CID_25227', u'DSSTox_RID_80764', u'DSSTox_GSID_45227', u'C22H24ClN3O5', u'CL-71563', u'W-107092', u'CHEBI:6549', u'Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)', u'Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz(b,f)(1,4)oxazepine (1:1)', u'SUM-3170', u'AZ-004', u'SR-01000002971', u'Loxapine succinate [USAN]', u'Loxapine succinate [USAN:USP]', u'Staccato-loxapine', u'butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine', u'Loxipine Succinate', u'Loxitane (TN)', u'Prestwick_304', u'Lopac-L-106', u'AC1Q5VQU', u'Opera_ID_1518', u'Loxapine succinate (USP)', u'SCHEMBL41643', u'MLS000758291', u'MLS001146961', u'MLS001401432', u'MLS002222201', u'SPECTRUM2300242', u'Loxapine succinate salt, solid', u'REGID_for_CID_71399', u'AC1L2G38', u'CHEMBL1201155', u'DTXSID3045227', u'CTK4G0318', u'AOB5330', u'ZX-AFC001324', u'HMS1568K06', u'HMS1922L14', u'HMS2051E05', u'HMS2093N20', u'HMS2095K06', u'HMS2232N05', u'HMS3262O21', u'HMS3374F02', u'HMS3393E05', u'HMS3652O10', u'HMS3712K06', u'Pharmakon1600-02300242', u'Tox21_110311', u'Tox21_500720', u'AZ-104', u'CCG-39497', u'HY-17390A', u'NSC759578', u's4086', u'AKOS015994711', u'Tox21_110311_1', u'CS-4285', u'KS-1083', u'LP00720', u'NC00011', u'NSC-759578', u'VA11204', u'NCGC00016160-01', u'NCGC00016160-03', u'NCGC00016160-04', u'NCGC00016160-05', u'NCGC00021145-11', u'NCGC00094068-01', u'NCGC00094068-02', u'NCGC00094068-03', u'NCGC00261405-01', u'O287', u'SAM001247061', u'LS-147408', u'EU-0100720', u'FT-0653022', u'SW196603-4', u'VU0239541-8', u'D00794', u'833L643', u'C-54162', u'SR-01000002971-2', u'SR-01000002971-6', u'SR-01000002971-9', u'2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine, Succinate', u'Loxapine succinate, United States Pharmacopeia (USP) Reference Standard', u'(E)-2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine succinate', u'2-Chloro-11-(4-methyl-1- piperazinyl)-dibenz[b,f][1,4]- oxazepine succinate', u'butanedioic acid; 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine', u'Loxitane', u'loxapine', u'Oxilapine', u'Adasuve', u'Loxapinesuccinatesalt', u'C18H18ClN3O', u'C18H18ClN3O.C4H6O4', u'CID71399', u'AR-1E0046', u'CS-O-30637', u'CL-62362', u'C18-H18-Cl-N3-O.C4-H6-O4', u'B1783', u'L-106', u'S-805'], 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate, Cl 71563, Daxolin, Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, butanedioate (1:1), Loxapac, Loxapine Succinate, Loxapine Succinate Salt, Loxitane, Loxitane Capsules, Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
• CAS: 27833-64-3
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 445.8961
• Fórmula: C₂₂H₂₄ClN₃O₅
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
• Clave InChI: YQZBAXDVDZTKEQ-UHFFFAOYSA-N